Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Tanja Dujic"'
Publikováno v:
Biomolecules & Biomedicine, Vol 21, Iss 6 (2021)
Type 2 diabetes (T2D) has a continuously rising prevalence worldwide. Pharmacogenetics has been recognized as a promising concept for pharmacological treatment of T2D, as antidiabetic drugs are not equally effective and safe for all patients, and the
Externí odkaz:
https://doaj.org/article/5e69cadc76364b3e94a99c9cf8a2be3e
Autor:
Tanja Dujic, Tamer Bego, Maja Malenica, Zelija Velija-Asimi, Emma Ahlqvist, Leif Groop, Ewan R. Pearson, Adlija Causevic, Sabina Semiz
Publikováno v:
Biomolecules & Biomedicine, Vol 19, Iss 4 (2019)
The response to metformin, the most commonly used drug for the treatment of type 2 diabetes (T2D), is highly variable. The common variant rs7903146 C>T within the transcription factor 7-like 2 gene (TCF7L2) is the strongest genetic risk factor associ
Externí odkaz:
https://doaj.org/article/f4eeead7bc3e4f349eb99895e8c00ad5
Autor:
Tamer Bego, Tanja Dujic, Barbara Mlinar, Sabina Semiz, Maja Malenica, Besim Prnjavorac, Barbara Ostanek, Janja Marc, Adlija Čaušević
Publikováno v:
Medicinski Glasnik, Vol 8, Iss 1, Pp 76-83 (2011)
Aim Lipin 1 is a recently discovered multifunctional protein involvedin the metabolism of lipids, while PPAR?? is involved in adipocytedifferentiation, and regulation of lipid metabolism. Up to now, LPIN1 and PPARG gene polymorphisms have been associ
Externí odkaz:
https://doaj.org/article/7507f2f3196849b893e53e4d42863c8f
Autor:
Sabina Semiz, Tanja Dujic, Barbara Ostanek, Besim Prnjavorac, Tamer Bego, Maja Malenica, Janja Marc, Adlija Causevic
Publikováno v:
Biomolecules & Biomedicine, Vol 10, Iss 4 (2010)
This is the first study performed in population from Bosnia & Herzegovina (BH), in which we analysed a significance of genetic variations in drug-metabolising enzyme, cytochrome P450 (CYP), in pathogenesis of Type 2 diabetes. We have determined allel
Externí odkaz:
https://doaj.org/article/73640d4b46034d888655f068edc83daa
Autor:
Maja Malenica, Tanja Dujic, Suzana Tihić-Kapidžić, Ermin Begovic, Jasmina Fočo-Solak, Sniježana Hasanbegović, Nermina Babić, Adlija Causevic
Publikováno v:
Journal of Medical Biochemistry
Journal of Medical Biochemistry, Vol 40, Iss 2, Pp 181-192 (2021)
Journal of Medical Biochemistry, Vol 40, Iss 2, Pp 181-192 (2021)
Altered levels of many hematological parameters have been directly associated with diabetes in adults, while studies on children with type 1 diabetes mellitus are lacking. The aim of this study was to determine hematological indices in diabetic Bosni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b15e2c60c6109cde8b571a48b6a10ce
http://europepmc.org/articles/PMC7982283
http://europepmc.org/articles/PMC7982283
Autor:
Adlija Causevic, Sabina Semiz, Janja Marc, Zelija Velija-Asimi, Tamer Bego, Besim Prnjavorac, Tanja Dujic, Vladimir Palicka, Jana Nekvindová, Maja Malenica
Publikováno v:
Journal of Medical Biochemistry, Vol 38, Iss 2, Pp 153-163 (2019)
Journal of Medical Biochemistry
Journal of Medical Biochemistry
Summary Background FTO, a gene recently discovered in genomewide associated studies for type 2 diabetes mellitus (T2D), play an important role in the management of energy homeostasis, nucleic acid demethylation and regulation of body fat mass by lipo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af13ae91409cc53422fa3fde72c3e98c
https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2019/1452-82581902153B.pdf
https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2019/1452-82581902153B.pdf
Autor:
Amar Elezović, Alisa Elezović, Aida Kulo, Tanja Dujic, Sandra Cvijić, Ewan R. Pearson, Selma Imamovic Kadric, Tamer Bego, Maja Malenica
Publikováno v:
Journal of Personalized Medicine
Volume 11
Issue 5
Journal of Personalized Medicine, Vol 11, Iss 367, p 367 (2021)
Volume 11
Issue 5
Journal of Personalized Medicine, Vol 11, Iss 367, p 367 (2021)
The antidiabetic drug gliclazide is partly metabolized by CYP2C19, the main enzyme involved in omeprazole metabolism. The aim of the study was to explore the interaction between omeprazole and gliclazide in relation to CYP2C19 phenotype using physiol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa0133c9f93d2501c03c5d32825af90f
Publikováno v:
Bosnian Journal of Basic Medical Sciences
Bosnian Journal of Basic Medical Sciences (2021)
Bosnian Journal of Basic Medical Sciences (2021)
Type 2 diabetes (T2D) has a continuously rising prevalence worldwide. Pharmacogenetics has been recognized as a promising concept for pharmacological treatment of T2D, as antidiabetic drugs are not equally effective and safe for all patients, and the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c35f47417024e4def9ba183513f3204
https://doi.org/10.17305/bjbms.2021.5646
https://doi.org/10.17305/bjbms.2021.5646
Autor:
Amela Dizdarevic, Bostandzic, Vanja Karlovic, Beslic, Ismana, Surkovic, Sefkija, Balic, Tanja, Dujic, Zelija Velija, Asimi, Azra, Burekovic
Publikováno v:
Medical Archives. 76:96
IDegLira( fixed combination of GLP 1 receptor agonist and insulin) has been shown to be effective in improving the glucoregulation in patients previously treated with oral therapy as well as individual components, GLP-1 receptor agonist or basal insu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eeb2078e8c568dcdd175cec515139bfe
https://doi.org/10.5455/medarh.2022.76.96-100
https://doi.org/10.5455/medarh.2022.76.96-100
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.